Axalta has remained at the forefront of the coatings industry by continually investing in innovative solutions. We engineer technologies that protect customers’ products—whether against heat, light, corrosion, abrasion, moisture, or chemicals—and add dimension and beauty with
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Superdraft Studio AG SIA Superdraft Studio AG SIA is an architectural studio based in Basel. We offer an attractive, diverse and challenging work environment with fair working conditions and flexible and family‑friendly employment models in a
Axalta has remained at the forefront of the coatings industry by continually investing in innovative solutions. We engineer technologies that protect customers’ products—whether against heat, light, corrosion, abrasion, moisture, or chemicals—and add dimension and beauty with
Axalta has remained at the forefront of the coatings industry by continually investing in innovative solutions. We engineer technologies that protect customers’ products—whether against heat, light, corrosion, abrasion, moisture, or chemicals—and add dimension and beauty with